
Certara (CERT) | Stock Overview & Key Data
Certara Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $45.48 on November 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Certara CERT | 1.76B Small-cap | 14.68% | -4.04% | -7.83% | -21.86% | 2.63% | -12.55% | -37.70% | -71.27% |
Veeva Systems VEEV | 46.10B Large-cap | 0.28% | 0.53% | 17.78% | 18.64% | 33.98% | 50.99% | 25.19% | 9.21% |
Ge Healthcare GEHC | 32.87B Large-cap | 3.08% | -4.26% | 2.13% | -17.71% | -8.14% | -13.67% | 26.89% | 26.89% |
Premier PINC | 1.93B Small-cap | 9.69% | 6.43% | 0.13% | 25.63% | 9.17% | 16.77% | -39.29% | -37.03% |
10x Genomics TXG | 1.51B Small-cap | -6.04% | 0.33% | 42.41% | 1.91% | -13.39% | -39.84% | -74.52% | -88.03% |
Phreesia PHR | 1.43B Small-cap | 2.54% | -4.93% | 6.42% | -6.80% | 7.23% | 16.83% | 4.53% | -9.48% |
Ownership & Short Interest
Certara Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Certara would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CERT's 52-week high and low?
- In the last 52 weeks, Certara reached a high of $15.69 (on February 14, 2025) and a low of $8.64 (on April 9, 2025).
- What is the market cap and P/E ratio for CERT?
- Curious about Certara's size and valuation? Its market capitalization stands at 1.76B. When it comes to valuation, the P/E ratio (trailing twelve months) is 218.80, and the forward P/E (looking ahead) is 21.88.
- Does CERT pay dividends? If so, what's the yield?
- As for dividends, Certara isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Certara's main competitors or similar companies to consider before investing?
When looking at Certara, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV46.10B Healthcare Health Information Services 50.99% 25.19% Ge Healthcare
GEHC32.87B Healthcare Health Information Services -13.67% 26.89% Premier
PINC1.93B Healthcare Health Information Services 16.77% -39.29% 10x Genomics
TXG1.51B Healthcare Health Information Services -39.84% -74.52% Phreesia
PHR1.43B Healthcare Health Information Services 16.83% 4.53% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Certara Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Certara's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 0.75%, the Debt to Equity ratio from the most recent quarter is 29.00, and its Gross Profit Margin stands at 61.06%.
- What is the recent revenue and earnings growth for CERT?
- Looking at Certara's growth, its revenue over the trailing twelve months (TTM) was $406M. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.10%, and quarterly earnings saw a YoY growth of 12.06%.
- How much of CERT stock is held by insiders and institutions?
- Wondering who owns Certara stock? Company insiders (like executives and directors) hold about 2.51% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 101.81%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.